We are live on
!
Find out more
CC
ClearArc Capital Portfolio holdings
AUM
$257M
1-Year Est. Return
33.81%
This Fund
S&P 500
This Quarter
Est. Return
+5.52%
1 Year Est. Return
+33.81%
3 Year Est. Return
+63.41%
5 Year Est. Return
+95.17%
10 Year Est. Return
–
AUM
$434M
AUM Growth
+$29.2M
(+7.2%)
Cap. Flow
+$11.3M
Cap. Flow
% of AUM
2.61%
Top 10 Holdings %
Top 10 Hldgs %
16.68%
Holding
407
New
26
Increased
249
Reduced
113
Closed
16
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SLB Ltd
SLB
|
+$2.08M |
| 2 |
SVC
Service Properties Trust
SVC
|
+$1.9M |
| 3 |
PPL
PPL Corp
PPL
|
+$1.79M |
| 4 |
Camden Property Trust
CPT
|
+$1.59M |
| 5 |
DRE
Duke Realty Corp.
DRE
|
+$1.53M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$1.55M |
| 2 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$1.1M |
| 3 |
BP
BP
|
+$798K |
| 4 |
Xerox
XRX
|
+$774K |
| 5 |
AstraZeneca
AZN
|
+$716K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 15.83% |
| 2 | Technology | 14.41% |
| 3 | Healthcare | 12.5% |
| 4 | Energy | 12.03% |
| 5 | Industrials | 10.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
PACCAR
PCAR
$58.3B
| $448K | 0.1% |
10,707
+191
| +2% | +$8.16K |
|
227
T. Rowe Price
TROW
$22.2B
| $446K | 0.1% |
5,285
+94
| +2% | +$7.67K |
|
|
FRX
228
DELISTED
FOREST LABORATORIES INC
FRX
| $446K | 0.1% |
4,510
+45
| +1% | +$4.2K |
|
229
Sysco
SYY
$37.5B
| $440K | 0.1% |
11,760
+187
| +2% | +$6.87K |
|
230
Intercontinental Exchange
ICE
$88.1B
| $436K | 0.1% |
11,540
-540
| -4% | -$21K |
|
|
STI
231
DELISTED
SunTrust Banks, Inc.
STI
| $429K | 0.1% |
10,709
+128
| +1% | +$4.98K |
|
|
VMRK
232
Vivmark Residential
VMRK
$47.2B
| $426K | 0.1% |
6,755
+109
| +2% | +$6.62K |
|
|
TYC
233
DELISTED
TYCO INTL PLC COM SHS (IRL)
TYC
| $423K | 0.1% |
8,860
+144
| +2% | +$6.49K |
|
234
Lumen
LUMN
$6.04B
| $417K | 0.1% |
11,516
-16,101
| -58% | -$578K |
|
235
Marriott International
MAR
$91.7B
| $416K | 0.1% |
6,490
-556
| -8% | -$33K |
|
|
BRCM
236
DELISTED
BROADCOM CORP CL-A
BRCM
| $416K | 0.1% |
11,199
+254
| +2% | +$8.32K |
|
237
Public Service Enterprise Group
PEG
$33.2B
| $415K | 0.1% |
10,184
+165
| +2% | +$6.41K |
|
238
Prologis
PLD
$127B
| $413K | 0.1% |
10,045
+158
| +2% | +$6.5K |
|
239
Humana
HUM
$45.7B
| $398K | 0.09% |
3,114
+71
| +2% | +$8.41K |
|
|
STJ
240
DELISTED
St Jude Medical
STJ
| $395K | 0.09% |
5,704
+82
| +1% | +$5.32K |
|
241
Chipotle Mexican Grill
CMG
$40.5B
| $393K | 0.09% |
33,150
+400
| +1% | +$4.33K |
|
242
Waste Management
WM
$83.1B
| $390K | 0.09% |
8,713
+149
| +2% | +$6.48K |
|
243
Weyerhaeuser
WY
$14.5B
| $389K | 0.09% |
11,762
+189
| +2% | +$5.71K |
|
244
Western Digital
WDC
$162B
| $388K | 0.09% |
5,557
+44
| +0.8% | +$2.95K |
|
245
Welltower
WELL
$168B
| $384K | 0.09% |
6,135
+381
| +7% | +$24K |
|
246
Aptiv
APTV
$9.05B
| $382K | 0.09% |
5,562
+40
| +0.7% | +$2.71K |
|
247
Healthpeak Properties
DOC
$14B
| $381K | 0.09% |
10,109
+161
| +2% | +$6.06K |
|
248
Edison International
EIX
$20.2B
| $380K | 0.09% |
6,544
+95
| +1% | +$5.32K |
|
249
Ventas
VTR
$44.5B
| $379K | 0.09% |
5,181
+84
| +2% | +$6.24K |
|
250
Viatris
VTRS
$20B
| $379K | 0.09% |
7,354
+136
| +2% | +$6.68K |
|
Similar funds
BO
GCA
QCM
AEPI
AC
LA
JFM
SHA
ClearArc Capital's Q2 2014 Portfolio in Review
As of Q2 2014, ClearArc Capital held 407 positions worth $434M, up 7.2% from $405M the previous quarter. Its ten largest holdings account for 17% of the portfolio.
ClearArc Capital's Q2 2014 filing shows 26 new, 249 increased, 113 reduced and 16 closed positions. Its largest new stake was Service Properties Trust: 12,988 shares worth $1.96M. The largest sale was Pfizer, an estimated $1.55M.
By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.
- ClearArc Capital's largest Q2 2014 buy was Service Properties Trust: 12,988 shares worth $1.96M.
- ClearArc Capital added most to SLB Ltd in Q2 2014, an estimated $2.08M increase.
- ClearArc Capital's biggest Q2 2014 reduction was Pfizer, cutting an estimated $1.55M.
- ClearArc Capital fully exited AstraZeneca in Q2 2014, selling an estimated $716K.
- ClearArc Capital's ten largest holdings make up 17% of its $434M portfolio in Q2 2014.
- ClearArc Capital opened 26 new positions and closed 16 in Q2 2014.
- ClearArc Capital's portfolio value rose 7.2% quarter-over-quarter to $434M.
Based on ClearArc Capital's 13F filing for Q2 2014, filed 14 Aug 2014.